MedPage Today on MSN
Vitamin D's Heart Prevention Win; ATTR Depleter Does So-So; Gene Therapy Trial Hold
Personalized vitamin D supplementation -- often requiring 5,000 IU of vitamin D each day -- did prove to have secondary ...
The Lysosomal Storage Disease Treatment Market is expanding due to increased diagnosis rates and innovations in enzyme ...
The "Fabry Disease Market - A Global and Regional Analysis: Focus on Route of Administration and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.The ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...
MyPEAK-1 Data Presented During Late-Breaking Session at AHA Scientific Sessions 2025 with Simultaneous Publication in Cardiovascular ...
Pharmaceutical Technology on MSN
Metagenomi culls 25% of its workforce and replaces CEO in reshuffle
Along with the layoffs, the reshuffle includes prioritisation of pipeline assets with the “highest probability of success.” ...
GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.
After a leading study caused the FDA to slap its most stringent warning on hormone replacement therapies for menopause more ...
Treatment Market is projected to grow at a healthy rate of around 13% by 2026. This growth is primarily driven by the ...
CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...
1d
We were shocked when our little girl’s EYEBROWS turned out to be hidden sign of dementia at just 3
LITTLE Lydia was diagnosed with a condition dubbed ‘childhood dementia’ after her parents spotted a child who looked similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback